PredxBio

Access our brand new White Paper here

Menu

The Team Behind SpaceIQ™

Team

Leadership across AI, spatial biology, and clinical translation.

S. Chakra Chennubhotla, PhD

Chief Executive Officer

Linkedin-in

Filippo Pullara, PhD

Chief Scientific Officer

Linkedin-in

A. Burak Tosun, PhD

Chief Technology Officer

Linkedin-in

Sambhav Dave

VP of Commercial Development

Linkedin-in

Brian Falkenstein, MS

Machine Learning Lead Engineer

Linkedin-in

Raymond Yan

Computational & Systems Biologist

Linkedin-in

Scientific and Business Advisors

D. Lansing Taylor, PhD

Co-founder, Scientific & Business Advisor

Linkedin-in

Michael J. Becich, M.D., PhD

Co-founder, Scientific Advisor

Linkedin-in

Jeffrey L. Fine, M.D.

Co-founder, Scientific Advisor

Linkedin-in

Board of Directors

PredxBio’s Board brings deep experience across cancer research, clinical leadership, and healthcare investment.

Stanley M. Marks, MD

Chairman
(Chairman, UPMC Hillman Cancer Center)

Bill Newlin

Director
(Newlin Investment Company)

S. Chakra Chennubhotla, PhD

Director & Co-founder

Linkedin-in

S. Chakra Chennubhotla, PhD

CEO & Co-Founder

Linkedin-in

S. Chakra Chennubhotla, PhD is Co-Founder and CEO of PredxBio, where he leads the company’s strategy and the development of SpaceIQ™, a clinical decision intelligence platform powering oncology drug development with AI-driven tissue intelligence. A pioneer in computational pathology and explainable AI, he has spent over two decades translating machine learning and spatial biology into deployable systems that reveal tumor microenvironment architecture and mechanisms of therapeutic response.

Before founding PredxBio, Dr. Chennubhotla was a tenured Associate Professor at the University of Pittsburgh, where he led multiple NIH and NSF-funded programs and raised over $7M in federal research funding focused on spatial microdomain biology and tumor heterogeneity. He earned his PhD in Computer Science from the University of Toronto. Dr. Chennubhotla is an inventor on multiple issued and pending patents in explainable AI and spatial analytics, and his research has appeared in Science Translational Medicine, Nature Communications, IEEE Transactions on Medical Imaging, and Cancer Research. His work forms the scientific and technical foundation of the SpaceIQ™ platform, now deployed across multiple pharmaceutical oncology programs.

Subscribe to our Newsletter

* indicates required





Registration

Join us for the Spatial Intelligence Summit. Complimentary and paid registration categories are listed below – hurry, early bird pricing ends on September 30.

We received your request! One of our team members will be in touch as soon as possible.

Submit your Resume

Download Whitepaper

Download Whitepaper

B. Dusty Majumdar, PhD

CHIEF EXECUTIVE OFFICER

Linkedin-in

B. Dusty Majumdar, PhD  is a seasoned leader in Precision Healthcare with more than 20 years of experience in building and successfully launching innovative technologies across oncology, multi-omics, Real-World Evidence (RWE). diagnostic imaging and liquid biopsy platforms leveraging some of the industry’s most advanced AI platforms, genomic and clinical simulations (digital twins), and emerging medical imaging technologies. Dr. Majumdar’s experience includes leading strategy and marketing as the Chief Marketing Officer (CMO) at IBM and multiple commercial and technical leadership roles at GE Healthcare, Exact Sciences and 3M. He has also led the commercial and strategic functions in a range of start-ups in the healthcare/biopharma space over the last few years.  Dr. Majumdar is a widely respected global leader in the healthcare industry and holds a Ph.D. from the University of Texas at Austin and a bachelor’s degree from the Indian Institute of Technology (IIT), Kharagpur.  He has authored several peer-reviewed scientific publications and holds multiple patents.

Joe Camaratta

Sr. VP Business Development

Linkedin-in

Joe Camaratta specializes in medical technology innovation and commercialization, taking products from concept to clinical adoption. He held executive positions for GE Healthcare and Siemens Healthcare and built businesses in medical imaging, cardiology, and oncology. He founded and led two early stage medical technology companies that apply artificial intelligence to improve clinical decision-making.

Joe holds a Master of Science degree in Computer Science from Rutgers University and a Bachelor of Science degree in Computer Science from Drexel University. He currently serves as an advisor to the Entreprenuerial Investing Program of the Crohn’s & Colitis Foundation, and the University Science Center QED Program focused on commercialization of academic innovations

Bruce Campbell, MS

VP Software Engineering

Linkedin-in

Bruce leads the software engineering and quality assurance teams at PredxBio. As the VP of Software Engineering, he is responsible for analytical infrastructure, product development and the commercialization of machine learning, image processing, and computational biology algorithms. Prior to joining PredxBio, Bruce was at IBM and Xylem in global Director of Data Science roles. He has over 20 years of experience in digital pathology algorithms and is highly motivated to deliver care through digital and computational pathology. He has multiple successful FDA 510k device applications, and multiple CLIA certified algorithms deployed in clinical practice.

Bruce holds a BS in Physics and MS in Applied Mathematics from the University of Rochester, an MS in Statistics from North Carolina State University, and is currently pursuing graduate mathematics studies at The Ohio State University. Bruce loves the outdoors. You can find him hiking and rock climbing in Appalachia.